Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
13,439
Total Claims
$1.2M
Drug Cost
952
Beneficiaries
$1,209
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+6%
Opioid rate vs peers
2.7% vs 2.6% avg
+13%
Cost per patient vs peers
$1,209 vs $1,068 avg
+3%
Brand preference vs peers
9.2% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
2.7%
Opioid Rate
367
Opioid Claims
$4,957
Opioid Cost
4.1%
Long-Acting Rate
Brand vs Generic
Brand: 1,229 claims · $880K
Generic: 12,077 claims · $266K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dulaglutide | 63 | $102K |
| Apixaban | 89 | $89K |
| Rivaroxaban | 63 | $71K |
| Empagliflozin | 50 | $62K |
| Semaglutide | 31 | $59K |
| Sitagliptin Phosphate | 28 | $45K |
| Mirabegron | 68 | $38K |
| Canagliflozin | 23 | $29K |
| Insulin Glargine,hum.Rec.Anlog | 23 | $24K |
| Fluticasone/Umeclidin/Vilanter | 26 | $21K |
| Dapagliflozin Propanediol | 18 | $20K |
| Fluticasone/Vilanterol | 21 | $16K |
| Atorvastatin Calcium | 991 | $12K |
| Insulin Nph Hum/Reg Insulin Hm | 14 | $12K |
| Budesonide/Formoterol Fumarate | 20 | $11K |
Prescribing Profile
Patient Profile
72
Avg Age
58%
Female
1.05
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About